SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001213900-21-042717
Filing Date
2021-08-16
Accepted
2021-08-16 10:56:54
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 425 ea145871-425_cmlifescience2.htm 425 17161
2 GRAPHIC image_001.jpg GRAPHIC 3285
  Complete submission text file 0001213900-21-042717.txt   23509
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
CM Life Sciences II Inc. (Filed by) CIK: 0001837412 (see all company filings)

IRS No.: 854298912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
CM Life Sciences II Inc. (Subject) CIK: 0001837412 (see all company filings)

IRS No.: 854298912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-40090 | Film No.: 211175431
SIC: 8731 Services-Commercial Physical & Biological Research